Clinician / Associate Medical Research Director
Fenway Health / The Fenway Institute
Boston, MA, United States
Dr. Taimur H. Khan, MD, MPH serves as an Infectious Diseases (ID) and Internal Medicine physician at Fenway Health, and Associate Medical Research Director at the Fenway Institute in Boston. Dr. Khan’s education is rooted in Tulane University, where he secured his MD and MPH. Post-Tulane, his specialization in ID was fostered at Boston Medical Center. At Fenway, he played a key role in integrating Cabotegravir into the medical facility, establishing a significant milestone in HIV prevention. He also led the rollout of Doxycycline Post-Exposure Prophylaxis (DoxyPEP), offering a fresh perspective on STI prevention. In his capacity at the Fenway Institute, Dr. Khan supervises clinical trials and drives education efforts, ensuring research findings are translated effectively to healthcare professionals and community members.
Disclosure(s): ViiV Healthcare/GSK: Grant/Research Support (Ongoing)
Thursday, October 12, 2023
1:45 PM – 3:00 PM US ET
957 - Pros and Cons of Viral Load Monitoring During PrEP – CON
Thursday, October 12, 2023
2:03 PM – 2:21 PM US ET